Doctor profile · Federal record
Dr. John Heymach, M.D.
Medical Oncology Physician (CMS: Medical Oncology) · Internal Medicine Physician · Houston, TX
- NPI 1417056565
- Accepts Medicare
- MIPS 79.4 / 100 · 2023
- 28 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1515 Holcombe Blvd
Houston, TX 770304000
(713) 792-6161 - Mailing address
-
Po Box 4439
Houston, TX 772104439
Credentials & registration
- NPI registered
- September 2006 — 20 yrs on file
- Profile last updated
- December 15, 2020
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Texas #M2645
- Medicaid
- TX #174118301
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1417056565. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
250
Distinct HCPCS
3
Medicare allowed
$33,462
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 164 | 54 | $144 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 70 | 40 | $98 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 16 | 16 | $184 |
In context: peer comparison
Among 72 peers in Houston Medical Oncology Physician, average services per provider: 632. This provider delivers 0.4× the peer median.Open Payments
Industry payments received
All-time total
$160,340
Transactions
101
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals Lp | 16 | $30,121.41 | |
| BioNTech Se | 8 | $25,361.44 | |
| Regeneron Pharmaceuticals, INC. | 22 | $20,604.50 | |
| Opko Pharmaceuticals, LLC | 2 | $20,000.00 | |
| Janssen Biotech, INC. | 16 | $13,053.06 | |
| Boehringer Ingelheim International GmbH | 13 | $9,558.50 | |
| Takeda Pharmaceuticals U.S.A., INC. | 3 | $7,247.34 | |
| Emd Serono Research & Development Institute, INC. | 1 | $6,588.90 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 4 | $6,537.64 | |
| GlaxoSmithKline, LLC. | 6 | $4,831.50 | |
| Pfizer INC. | 3 | $4,473.19 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $3,912.76 | |
| Abbvie INC. | 2 | $3,475.00 | |
| Emd Serono, INC. | 1 | $3,000.00 | |
| Daiichi Sankyo INC. | 1 | $1,250.00 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
51
Patients
0
Total drug cost
$627,947
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Tagrisso (Osimertinib Mesylate) | Brand | 38 | 0 | $620,003 |
| Eliquis (Apixaban) | Brand | 13 | 0 | $7,944 |
Frequently asked questions
What is Dr. John Heymach's medical specialty?
Dr. John Heymach practices Medical Oncology Physician in Houston, TX.
Where does Dr. John Heymach practice?
Dr. John Heymach practices at 1515 Holcombe Blvd, Houston, TX 770304000. Office phone: 7137926161.
What is Dr. John Heymach's NPI?
Dr. John Heymach's National Provider Identifier (NPI) is 1417056565, issued by NPPES.
Does Dr. John Heymach accept Medicare assignment?
Yes. Dr. John Heymach accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. John Heymach commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99215); Established patient office or other outpatient visit (HCPCS 99214); New patient office or other outpatient visit (HCPCS 99205). Source: CMS Medicare Physician & Other Practitioners file.